DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Grifulvin V (Griseofulvin) - Published Studies

 
 



Grifulvin V Related Published Studies

Well-designed clinical trials related to Grifulvin V (Griseofulvin)

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. [2008.07]

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials. [2008.03.29]

Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. [2005.02]

Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. [2004.01]

A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. [2002.05]

Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. [2001.09]

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. [2001.02]

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. [2001]

Personal hygiene as an alternative to griseofulvin in the treatment of tinea cruris. [2000.03]

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. [2000.01]

A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. [1999.04]

Griseofulvin and terbinafine in the treatment of tinea capitis in children. [1998.02.27]

A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. [1997.04]

Griseofulvin and fluvoxamine interactions with the metabolism of theophylline. [1997.02]

Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin. [1997.01]

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. [1995.08]

Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. [1995.05]

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group. [1995.01]

Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. [1994.10]

Topical griseofulvin in the treatment of dermatophytoses. [1994.01]

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. [1993.10]

Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study. [1993.07]

A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study. [1992.09]

Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. [1992]

Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. [1991.08]

A comparative study of terbinafine versus griseofulvin in 'dry-type' dermatophyte infections. [1991.02]

Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis. [1990.10]

A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris. [1990.05]

A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis. [1989.11]

Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. [1989.07]

Treating tinea capitis: should ketoconazole replace griseofulvin? [1988.06]

Double blind study of ketoconazole and griseofulvin in dermatophytoses. [1988.01]

Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion. [1987.12]

Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis. [1987.10]

Well-designed clinical trials possibly related to Grifulvin V (Griseofulvin)

A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. [2010.09]

A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. [2005.11]

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. [2004.03]

Treatment of kerions. [1994.03]

Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. [1992.02]

Other research related to Grifulvin V (Griseofulvin)

Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. [2013]

A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. [2011.11]

In vivo efficacy of griseofulvin against multiple myeloma. [2011.08]

Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. [2011.04]

A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. [2011]

Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury. [2010.10]

Tinea capitis: predictive value of symptoms and time to cure with griseofulvin treatment. [2010.04]

Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying. [2010.03]

Tinea capitis: predictive value of symptoms and time to cure with griseofulvin treatment. [2010.03]

Prescription auditing of griseofulvin in a tertiary care teaching hospital. [2009.11]

[Treatment of 2 cases of kerions with griseofulvin and oral steroids] [2009.11]

In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors. [2009.09.10]

Solubilisation of griseofulvin, quercetin and rutin in micellar formulations of triblock copolymers E62P39E62 and E137S18E137. [2009.08.13]

Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols. [2009.08]

The use of liquid self-microemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin. [2009.02]

A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis? [2009.02]

Enhanced oral bioavailability of griseofulvin via niosomes. [2009]

Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states. [2008.10.02]

Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: A single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states. [2008.07.15]

Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. [2008.04]

Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug. [2008.03.20]

Improving the high variable bioavailability of griseofulvin by SEDDS. [2007.12]

In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin. [2007.09]

Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study. [2007.06.04]

Analysis of sperm karyotypes in a patient treated with griseofulvin. [2007.05]

Preparation of hydrogels of griseofulvin for dermal application. [2006.12.01]

Efficacy of topical griseofulvin in treatment of tinea corporis. [2006.05]

Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin. [2006.05]

Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin. [2005.12.01]

Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization. [2004.11]

Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. [2004.11]

A population-based case-control study of oral griseofulvin treatment during pregnancy. [2004.09]

Serum sickness-like reaction associated with griseofulvin. [2004.04]

Influence of Griseofulvin treatment on semen quality in the dog. [2004.01]

Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in Guinea pigs and binding to human stratum corneum. [2004.01]

Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. [2003.03.26]

Effect of griseofulvin on the toxicity of signal grass (Brachiaria decumbens) in sheep. [2003.03]

[Tinea capitis. Therapeutic options in the post-griseofulvin era] [2002.12]

In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. [2002.04]

[Griseofulvin] [2001.12]

Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer. [2001.10.09]

Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. [2001.02.01]

Clinico-myocological profile of tinea capitis in North India and response to griseofulvin. [2001.01]

Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone. [2000.11]

Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver. [2000.08]

Oral griseofulvin remains the treatment of choice for tinea capitis in children. [2000.07]

Treatment of tinea capitis: beyond griseofulvin. [1999.06]

Griseofulvin-induced aneuploidy and meiotic delay in male mouse germ cells: detected by using conventional cytogenetics and three-color FISH. [1999.05.17]

Altered microtubule-associated tau messenger RNA isoform expression in livers of griseofulvin- and 3,5-diethoxycarbonyl-1, 4-dihydrocollidine-treated mice. [1999.03]

Detection of chromosome loss and gain induced by griseofulvin, estramustine, and vanadate in binucleated lymphocytes using FISH analysis. [1999]

Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. [1998.06]

Griseofulvin-induced hepatopathy due to abnormalities in heme pathway. [1997.08]

Microphthalmia, brachygnathia superior, and palatocheiloschisis in a foal associated with griseofulvin administration to the mare during early pregnancy. [1997.06]

Response to initial griseofulvin therapy in pediatric patients with tinea capitis. [1997.04]

A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. [1997.03]

Bullous drug eruption to griseofulvin in a man with Hailey-Hailey disease. [1995.11]

Efficacy of griseofulvin and itraconazole in the treatment of experimentally induced dermatophytosis in cats. [1995.08.15]

Nephrotic syndrome related to systemic lupus erythematosus after griseofulvin therapy. [1995.08]

Determination of the structure of an N-substituted protoporphyrin isolated from the livers of griseofulvin-fed mice. [1995.04.15]

Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. [1995.04]

Griseofulvin absorption from different sites in the human small intestine. [1994.12]

[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine] [1994.11.19]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017